Clinical Trial Update: Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure [Phase 3]

View source ↗

Summary

This clinical trial update concerns the VSV-EBOV Ebola vaccine. It includes assessment of a booster dose in individuals at potential occupational risk and is in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• VSV-EBOV (vesicular stomatitis virus-based Ebola vaccine (rVSV-ZEBOV))

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Ebola Vaccine | Phase 3 | Status: NOT_YET_RECRUITING